194 related articles for article (PubMed ID: 3132505)
1. Heterogeneity of a murine B cell lymphoma. Isolation and characterization of idiotypic variants.
Starnes CO; Carroll WL; Campbell MJ; Houston LL; Apell G; Levy R
J Immunol; 1988 Jul; 141(1):333-9. PubMed ID: 3132505
[TBL] [Abstract][Full Text] [Related]
2. Idiotype variants emerging after anti-idiotype monoclonal antibody therapy of a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1989 Jan; 142(1):343-51. PubMed ID: 2783325
[TBL] [Abstract][Full Text] [Related]
3. Anti-idiotypic antibodies recognizing stable epitopes limit the emergence of idiotype variants in a murine B cell lymphoma.
Weiner GJ; Kaminski MS
J Immunol; 1990 Mar; 144(6):2436-45. PubMed ID: 1690244
[TBL] [Abstract][Full Text] [Related]
4. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies.
Meeker T; Lowder J; Cleary ML; Stewart S; Warnke R; Sklar J; Levy R
N Engl J Med; 1985 Jun; 312(26):1658-65. PubMed ID: 3923352
[TBL] [Abstract][Full Text] [Related]
5. Idiotypic variation in a human B lymphoma cell line.
Berinstein N; Campbell MJ; Lam K; Carswell C; Levy S; Levy R
J Immunol; 1990 Jan; 144(2):752-8. PubMed ID: 2295809
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of anti-idiotype antibody-resistant variants of a murine B cell lymphoma.
Roth MS; Weiner GJ; Allen EA; Terry VH; Harnden CE; Boehnke M; Kaminski MS; Ginsburg D
J Immunol; 1990 Jul; 145(2):768-77. PubMed ID: 2114449
[TBL] [Abstract][Full Text] [Related]
7. Molecules recognized by anti-idiotypic monoclonal antibodies to the B cell lymphoma, BCL1.
Tamura GS; McGrath MS; Weissman IL
J Mol Cell Immunol; 1987; 3(4):243-53. PubMed ID: 3509925
[TBL] [Abstract][Full Text] [Related]
8. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
Kwak LW; Campbell M; Levy R
Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139
[TBL] [Abstract][Full Text] [Related]
9. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
[TBL] [Abstract][Full Text] [Related]
10. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype.
Raffeld M; Neckers L; Longo DL; Cossman J
N Engl J Med; 1985 Jun; 312(26):1653-8. PubMed ID: 3923351
[TBL] [Abstract][Full Text] [Related]
12. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.
Thielemans K; Maloney DG; Meeker T; Fujimoto J; Doss C; Warnke RA; Bindl J; Gralow J; Miller RA; Levy R
J Immunol; 1984 Jul; 133(1):495-501. PubMed ID: 6609992
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of action.
Basham TY; Race ER; Campbell MJ; Reid TR; Levy R; Merigan TC
J Immunol; 1988 Oct; 141(8):2855-60. PubMed ID: 2971732
[TBL] [Abstract][Full Text] [Related]
14. Ig isotype switching in B lymphocytes. Isolation and characterization of clonal variants of the murine Ly-1+ B cell lymphoma, CH12, expressing isotypes other than IgM.
Arnold LW; Grdina TA; Whitmore AC; Haughton G
J Immunol; 1988 Jun; 140(12):4355-63. PubMed ID: 3131432
[TBL] [Abstract][Full Text] [Related]
15. Immunoselection of B cell hybridomas with anti-idiotypic antisera to study the role of heavy and light chains for idiotype expression and antibody activity.
Ju ST; Pincus SH; Kunar J; Dorf ME
J Immunol; 1984 May; 132(5):2485-90. PubMed ID: 6425406
[TBL] [Abstract][Full Text] [Related]
16. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
George AJ; Tutt AL; Stevenson FK
J Immunol; 1987 Jan; 138(2):628-34. PubMed ID: 3491853
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.
Maloney DG; Kaminski MS; Burowski D; Haimovich J; Levy R
Hybridoma; 1985; 4(3):191-209. PubMed ID: 3899906
[TBL] [Abstract][Full Text] [Related]
18. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
Hatzubai A; Maloney DG; Levy R
J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351
[TBL] [Abstract][Full Text] [Related]
19. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
[TBL] [Abstract][Full Text] [Related]
20. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.
Kwak LW; Campbell MJ; Czerwinski DK; Hart S; Miller RA; Levy R
N Engl J Med; 1992 Oct; 327(17):1209-15. PubMed ID: 1406793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
